CAS 16680-47-0: Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt
Formula:C18H20O5S·Na
InChI:InChI=1S/C18H20O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3-5,10,14,16H,2,6-9H2,1H3,(H,20,21,22);/t14-,16+,18+;/m1./s1
InChI key:InChIKey=RMFRALSRVMTLBI-QWAPEVOJSA-N
SMILES:C[C@@]12[C@](C=3[C@@](C=4C(CC3)=CC(OS(=O)(=O)O)=CC4)(CC1)[H])(CCC2=O)[H].[Na]
Synonyms:- 17-Oxoestra-1,3,5(10),7-Tetraen-3-Yl Hydrogen Sulfate
- 17-Oxoestra-1,3,5(10),7-tetraen-3-yl sodium sulfate
- Conjugated estrogens: sodium equilin sulfate
- Equilin sodium sulfate
- Equilin, sulfate, sodium salt
- Equilin, sulfate, sodium salt (6CI)
- Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt (1:1)
- Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-, hydrogen sulfate sodium salt (8CI)
- Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-, hydrogen sulfate, sodium salt
- Sodium 17-Oxoestra-1,3,5(10),7-Tetraen-3-Yl Sulfate
- Sodium equilin 3-monosulfate
- See more synonyms
Sort by
Found 4 products.
Equilin 3-sulfate sodium salt
CAS:Equilin 3-sulfate sodium salt is a treatment for vaginal atrophy. It has been shown to be effective in treating the following: body mass index (BMI) of >30 kg/m2, sodium citrate bowel disease, carcinogenic potential, estrogen conjugated, analytical method (HPLC), estradiol benzoate, diabetic neuropathy and hepatic steatosis. Equilin 3-sulfate sodium salt is not detected by chemical stability or symptoms.Formula:C18H19NaO5SPurity:Min. 95%Molecular weight:370.4 g/molEquilin 3-Sulfate Sodium Salt (Stabilized with TRIS, 50% w/w)
CAS:Controlled ProductStability Hygroscopic Applications Equilin 3-Sulfate Sodium Salt, is a metabolite of Equilin (E592800). References Hajdu, A., et al.: Experientia, 27, 956 (1971), Adams, W.P., et al.: J. Pharma. Sci., 68, 986 (1979),Formula:C18H19O5S·NaColor and Shape:NeatMolecular weight:370.40Equilin 3-Sulfate Sodium Salt
CAS:Formula:C18H19O5S·NaColor and Shape:Off-White SolidMolecular weight:347.41 22.99
